-
N-[2-(4-{3-[(propan-2-yl)amino]pyridin-2-yl}piperazine-1-carbonyl)-1H-indol-5-yl]methanesulfonamide; methanesulfonic acid
-
ChemBase ID:
154903
-
Molecular Formular:
C23H32N6O6S2
-
Molecular Mass:
552.66678
-
Monoisotopic Mass:
552.18247477
-
SMILES and InChIs
SMILES:
CC(C)Nc1cccnc1N1CCN(CC1)C(=O)c1cc2cc(ccc2[nH]1)NS(=O)(=O)C.CS(=O)(=O)O
Canonical SMILES:
CS(=O)(=O)O.CC(Nc1cccnc1N1CCN(CC1)C(=O)c1cc2c([nH]1)ccc(c2)NS(=O)(=O)C)C
InChI:
InChI=1S/C22H28N6O3S.CH4O3S/c1-15(2)24-19-5-4-8-23-21(19)27-9-11-28(12-10-27)22(29)20-14-16-13-17(26-32(3,30)31)6-7-18(16)25-20;1-5(2,3)4/h4-8,13-15,24-26H,9-12H2,1-3H3;1H3,(H,2,3,4)
InChIKey:
MEPNHSOMXMALDZ-UHFFFAOYSA-N
-
Cite this record
CBID:154903 http://www.chembase.cn/molecule-154903.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
|
IUPAC name
|
|
N-[2-(4-{3-[(propan-2-yl)amino]pyridin-2-yl}piperazine-1-carbonyl)-1H-indol-5-yl]methanesulfonamide; methanesulfonic acid
|
|
|
|
|
IUPAC Traditional name
|
|
delavirdine; methanesulfonic acid
|
|
|
|
|
Synonyms
|
|
N-[2-[[4-[3-[(1-Methylethyl)amino]-2-pyridinyl]-1-piperazinyl]carbonyl]-1H-indol-5-yl]methanesulfonamide mesylate
|
|
Delavirdine mesylate
|
|
N-[2-[[4-[3-[(1-Methylethyl)amino]-2-pyridinyl]-1-piperazinyl]carbonyl]-1H-indol-5-yl]methanesulfonamide Methanesulfonate
|
|
U-90152S
|
|
Delavirdine Mesylate
|
|
|
|
|
CAS Number
|
|
|
MDL Number
|
|
|
PubChem SID
|
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
|
Acid pKa
|
9.392162
|
H Acceptors
|
6
|
H Donor
|
3
|
LogD (pH = 5.5)
|
-0.08998393
|
LogD (pH = 7.4)
|
0.9233841
|
Log P
|
1.0243266
|
Molar Refractivity
|
126.6434 cm3
|
Polarizability
|
48.65747 Å3
|
Polar Surface Area
|
110.43 Å2
|
Rotatable Bonds
|
5
|
Lipinski's Rule of Five
|
false
|
DETAILS
DETAILS
Sigma Aldrich
TRC
Sigma Aldrich -
PZ0180
|
Legal Information Sold for research purposes under agreement from Pfizer Inc. Biochem/physiol Actions Delavirdine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). It is used as part of highly active antiretroviral therapy (HAART) for the treatment of human immunodeficiency virus (HIV) type 1. |
PATENTS
PATENTS
PubChem Patent
Google Patent